Transcriptomics

Dataset Information

0

Alanyl-glutamine in peritoneal dialysis fluids - a randomized controlled phase I/II trial


ABSTRACT: In this open-label randomized controlled phase I/II trial, 20 stable peritoneal dialysis patients underwent two 4 h dwells with acidic glucose-based PDF, with and without 8 mM alanyl-glutamine (AlaGln) in a cross-over design. Unsupervised hierarchical clustering of transcriptomics data suggested specific effects of AlaGln in patients who had previously suffered from peritonitis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE57070 | GEO | 2020/01/24

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2018-01-25 | E-MTAB-5462 | biostudies-arrayexpress
2018-01-25 | E-MTAB-5461 | biostudies-arrayexpress
| PRJEB19316 | ENA
2017-01-23 | E-MTAB-5439 | biostudies-arrayexpress
2023-11-22 | GSE246101 | GEO
2023-11-22 | GSE246100 | GEO
2012-12-13 | PXD006863 | Pride
2018-08-14 | PXD006371 | Pride
2023-12-31 | E-MTAB-12875 | biostudies-arrayexpress
2019-01-24 | GSE125498 | GEO